|
Powered by Cell Signaling Technology |
Site Information |
---|
KRKLPCDtPGQGLtC SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 454110 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Kinases, in vitro: | |
Putative upstream phosphatases: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on SRC-3: | |
Effects of modification on biological processes: | |
Inhibit interaction with: |
References | |
---|---|
Wang X, et al. (2021) Therapeutic targeting of nemo-like kinase in primary and acquired endocrine-resistant breast cancer. Clin Cancer Res
33542078 Curated Info |
|
Nikolai BC, et al. (2016) HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res 76, 1463-75
26833126 Curated Info |
|
Foulds CE, et al. (2013) Proteomic Analysis of Coregulators Bound to ERĪ± on DNA and Nucleosomes Reveals Coregulator Dynamics. Mol Cell 51, 185-99
23850489 Curated Info |
|
Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546 Curated Info |
|
Li C, et al. (2008) Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol Cell 31, 835-49
18922467 Curated Info |
|
Wu RC, et al. (2004) Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15, 937-49
15383283 Curated Info |